SKI Market

Indian Indices

Sensex

82,269.78 -296.59
( -0.36%)

Global Indices

Nasdaq

49,070.31 33.70
(0.07%)

Dow Jones

6,988.25 -10.78
(-0.15%)

Hang Seng

53,392.10 16.50
(0.03%)

Nikkei 225

10,179.25 24.82
(0.24%)

Forex

USD-INR

91.84 0.21
(0.23%)

EUR-INR

109.94 0.65
(0.59%)

GBP-INR

126.67 0.83
(0.66%)

JPY-INR

0.60 0.00
(0.62%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524636

INE102E01018

-9.9177201

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

221.53

EPS(TTM)

Face Value()

Div & Yield %

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	109.30	39.64	30.99	60.52	52.03	13.72
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	109.30	39.64	30.99	60.52	52.03	13.72
Other Income	1.31	0.10	0.14	1.36	2.28	4.02
Stock Adjustments	3.76	1.53	4.63	-4.55	6.39	-0.59
Total Income	114.37	41.27	35.76	57.33	60.70	17.15
EXPENDITURE :
Raw Materials	100.23	35.06	28.64	42.67	43.02	14.99
Power & Fuel Cost	6.24	4.15	4.16	3.04	2.79	1.00
Employee Cost	6.81	5.96	5.74	0.58	4.08	2.50
Other Manufacturing Expenses	6.00	3.28	2.43	6.31	2.88	1.32
Selling & Administrative Expenses	3.31	2.39	1.75	1.88	1.79	1.17
Miscellaneous Expenses	0.49	0.04	0.87	0.82	0.01	0.01
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	123.07	50.89	43.59	55.31	54.57	20.99
Operating Profit	-8.71	-9.62	-7.83	2.02	6.12	-3.85
Interest	2.03	1.59	1.49	0.92	1.78	1.09
Gross Profit	-10.74	-11.21	-9.32	1.10	4.34	-4.94
Depreciation	0.82	2.66	2.05	1.59	1.20	1.00
Profit Before Tax	-11.56	-13.87	-11.37	-0.49	3.14	-5.94
Tax	0.16	0.00	0.00	0.00	0.00	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-2.03	-10.39	0.20	0.12	0.21	-0.15
Reported Net Profit	-9.68	-3.48	-11.57	-0.61	2.93	-5.79
Extraordinary Items	-0.27	0.04	-0.72	0.43	2.04	3.99
Adjusted Net Profit	-9.41	-3.52	-10.85	-1.04	0.89	-9.78
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	-63.88	-60.40	-48.83	-48.22	-51.15	-45.36
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	-73.56	-63.88	-60.40	-48.83	-48.22	-51.15
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	-2.62	-1.04	-8.15	-0.43	2.87	-5.67
Earnings Per Share(Adj)-Unit Curr	-2.62	-1.04	-8.15	-0.43	2.87	-5.67
Book Value-Unit Curr	-6.77	-6.18	-32.53	-24.38	-37.27	-40.14
Book Value(Adj)-Unit Curr	-6.77	-6.18	-32.53	-24.38	-37.27	-40.14

82,269.78 -296.59 ( -0.36%)

49,070.31 33.70 (0.07%)

6,988.25 -10.78 (-0.15%)

53,392.10 16.50 (0.03%)

10,179.25 24.82 (0.24%)

91.84 0.21 (0.23%)

109.94 0.65 (0.59%)

126.67 0.83 (0.66%)

0.60 0.00 (0.62%)